Novo Seeds A/S
Novo Seeds is the seed arm of Novo A/S, an international financial venture fund with offices in Copenhagen, San Francisco and London. Novo invests approx USD 100 mill per year and has numerous successful exits since its inception in 2000. Currently Novo has > 40 portfolio companies, of which 60% are in US and 40% in Europe. Visit website
Seed Capital Denmark
Seed finances and assists entrepreneurs based in Denmark and Southern Sweden developing Life Sciences, IT, and cleantech companies. In addition, SEED Capital acts as venture partner for the government funded pre-seed investments through DTU Symbion Innovation. Seventeen professionals manage >50 portfolio companies and total funds of USD 175 mill. Visit website
LFI Life Science Investments A/S
A life science investment arm of LFI, the industrial entity of The Lundbeck Foundation. An evergreen fund formed in 2009 with a broad focus on investments in life science companies through direct investments as well as through selected fund to fund investments. Visit website
OSI Pharmaceuticals
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality, novel and differentiated targeted medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity. Visit website
